Refine
Year of publication
Document Type
- Article (150)
- Preprint (120)
- Working Paper (1)
Language
- English (271)
Has Fulltext
- yes (271)
Is part of the Bibliography
- no (271)
Keywords
- BESIII (17)
- e +-e − Experiments (13)
- Branching fraction (9)
- Particle and Resonance Production (7)
- Spectroscopy (6)
- Hadronic decays (5)
- Quarkonium (5)
- Branching fractions (4)
- Charm Physics (4)
- Exotics (4)
Institute
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
(2017)
Global changes in chromatin accessibility may drive cancer progression by reprogramming transcription factor (TF) binding. In addition, histone acetylation readers such as bromodomain-containing protein 4 (BRD4) have been shown to associate with these TFs and contribute to aggressive cancers including prostate cancer (PC). Here, we show that chromatin accessibility defines castration-resistant prostate cancer (CRPC). We show that the deregulation of androgen receptor (AR) expression is a driver of chromatin relaxation and that AR/androgen-regulated bromodomain-containing proteins (BRDs) mediate this effect. We also report that BRDs are overexpressed in CRPCs and that ATAD2 and BRD2 have prognostic value. Finally, we developed gene stratification signature (BROMO-10) for bromodomain response and PC prognostication, to inform current and future trials with drugs targeting these processes. Our findings provide a compelling rational for combination therapy targeting bromodomains in selected patients in which BRD-mediated TF binding is enhanced or modified as cancer progresses.